Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
Status:
Completed
Trial end date:
2018-02-08
Target enrollment:
Participant gender:
Summary
The study consists of a screening visit, out-patient treatment of a moderate or severe
migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study
Visit 2-7 days after dosing.